NPS Intelligence (beta)

WEEKLY DIGEST · ISSUE 13

Issue 13 · Sector Highlight · 2026-07-21

Healthcare & Pharma

Healthcare & Pharma has long outscored the cross-sector median, and that trend continues: 593 scored disclosures deliver a median of 83.0, lifted by core provider and telehealth models and weighed down by insurance-heavy businesses. RareMed and Health Network One both posted perfect 100.0 scores, while Humana and CSL appeared in the bottom quintile with single-digit readings.

Solid, stable performance with a recent dip

The 593 Healthcare & Pharma disclosures recorded in the database deliver an average of 78.6 and a median of 83.0, well above the corpus median of 74. This nine-point advantage reflects the sector's enduring emphasis on patient experience and the structural incentives—reimbursement, reputation, and retention—that keep satisfaction top-of-mind. Within the mix, pure-play healthcare providers and SaaS-enabled services pull the distribution upward, while insurance and hospitality-adjacent segments apply downward drag.

Volume growth has been steady: from four disclosures in 2016 to a peak of 95 in 2025. The first half of 2026 contributed 89 data points, on pace to match or exceed last year's total. Median scores climbed from 71.5 in 2016 to 88.0 in 2020, then settled into a range around 83.0 from 2021 onward. The 2026 average of 78.0 represents a modest softening, driven in part by a handful of very weak scores surfacing in the first half of the year.

NPS evolution

After an early ramp through 2020, the sector's median has plateaued in the low-to-mid 80s. The 2022 dip to 73.5 average (likely a composition effect from fewer disclosures that year) recovered quickly, and the 2026 year-to-date average of 78.0 sits just below the long-run trend line. Mature providers are holding scores; newer entrants span a wider quality band.

707479838720162017201820192020202120222023202420252026
Average disclosed NPS by year — Healthcare & Pharma

Disclosure volume

Annual disclosure counts have grown consistently since 2016, surging through 2020 and 2021 as telemedicine and digital health models gained visibility. The 2022–2023 pause in growth gave way to a rebound in 2024 and 2025, and the 2026 run rate suggests this year will match or slightly trail 2025's total of 95.

41441395883364985958920162017201820192020202120222023202420252026
Disclosure volume by year — Healthcare & Pharma

Company stories

Oscar Health's 57-point climb

Oscar Health rose from 30.0 in April 2021 to 87.0 in August 2025 across six disclosures, the largest gain in the dataset. The insurer's investment in concierge care teams, digital-first enrollment, and transparent plan design appears to have transformed member sentiment over four years.

Teladoc's sharp reversal

Teladoc fell from 95.0 in June 2021 to 60.0 one month later, a 35-point drop that coincided with rapid post-pandemic scale-up and integration challenges following the Livongo acquisition. One Medical experienced a similar 30-point decline from 90.0 to 60.0 between early 2020 and early 2021, reflecting the strains of pandemic-era demand surges.

Outliers on the low end

RACGP, the Royal Australian College of General Practitioners, recorded −50.0 in September 2022, the sector's only negative score and a rare glimpse of professional-body member dissatisfaction. Humana's 13.0 disclosure in February 2026 and CSL's 9.41 score in July 2024 illustrate that even large, established brands can struggle when service complexity or claims friction overwhelms the customer relationship.

Fresh in 2026

Recent disclosures highlight momentum in appointment-driven care and the persistent challenge of large-scale payer models:

Older nuggets worth a second look

What I'd take away. Healthcare & Pharma consistently outscores the broader corpus, but the gap narrows when insurance and pharmacy-adjacent businesses dominate the mix. The standout performers are niche providers and tech-enabled care models that keep friction low and touchpoints personal. Large payers and complex service chains remain vulnerable to sharp declines when operational integration lags customer expectations.

Generated 2026-07-21 · Source: NPS Intelligence database · 593 scored canonical disclosures.

← All digests